Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.430
+0.090 (6.72%)
Mar 11, 2025, 4:00 PM EST - Market closed
Neumora Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 142.15 | 374.04 | 240.94 | 409.25 | 191.98 | Upgrade
|
| Short-Term Investments | 165.43 | 79.94 | 130.94 | - | - | Upgrade
|
| Cash & Short-Term Investments | 307.58 | 453.98 | 371.88 | 409.25 | 191.98 | Upgrade
|
| Cash Growth | -32.25% | 22.08% | -9.13% | 113.18% | - | Upgrade
|
| Other Receivables | - | - | 0.92 | 0.2 | 0.15 | Upgrade
|
| Receivables | - | - | 0.92 | 0.2 | 0.15 | Upgrade
|
| Prepaid Expenses | 5.26 | 18 | 1.62 | 1.2 | 0.78 | Upgrade
|
| Restricted Cash | 1.21 | - | 0.05 | 0.13 | 0.13 | Upgrade
|
| Other Current Assets | - | 6.3 | 13.48 | 4.84 | 0.81 | Upgrade
|
| Total Current Assets | 314.06 | 478.28 | 387.96 | 415.6 | 193.84 | Upgrade
|
| Property, Plant & Equipment | 2.92 | 6.86 | 10.64 | 4.04 | 3.92 | Upgrade
|
| Long-Term Investments | - | 9.85 | 23.51 | - | - | Upgrade
|
| Long-Term Deferred Charges | - | - | 2.9 | 1.83 | - | Upgrade
|
| Other Long-Term Assets | - | 1.21 | 1.23 | 7.82 | 0.18 | Upgrade
|
| Total Assets | 316.97 | 496.2 | 426.23 | 429.3 | 197.95 | Upgrade
|
| Accounts Payable | 3.31 | 0.34 | 7.15 | 1.64 | 2.4 | Upgrade
|
| Accrued Expenses | 24.59 | 21.26 | 11.54 | 19.1 | 5.6 | Upgrade
|
| Current Portion of Leases | 1.85 | 3.38 | 3.37 | 1.06 | 0.76 | Upgrade
|
| Other Current Liabilities | 0.13 | 0.14 | 1.64 | 1.49 | 0.61 | Upgrade
|
| Total Current Liabilities | 29.89 | 25.11 | 23.7 | 23.28 | 9.37 | Upgrade
|
| Long-Term Leases | - | 1.85 | 5.07 | 1 | 1.28 | Upgrade
|
| Other Long-Term Liabilities | 0.02 | 0.16 | 0.63 | 0.39 | - | Upgrade
|
| Total Liabilities | 29.91 | 27.12 | 29.4 | 24.66 | 10.65 | Upgrade
|
| Common Stock | 0.02 | 0.02 | 0 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 1,234 | 1,173 | 21.43 | 11.37 | 4.9 | Upgrade
|
| Retained Earnings | -947.22 | -703.43 | -467.51 | -336.61 | -99.29 | Upgrade
|
| Comprehensive Income & Other | 0.06 | -0.08 | -0.77 | - | - | Upgrade
|
| Total Common Equity | 287.06 | 469.08 | -446.85 | -325.22 | -94.38 | Upgrade
|
| Shareholders' Equity | 287.06 | 469.08 | 396.84 | 404.64 | 187.3 | Upgrade
|
| Total Liabilities & Equity | 316.97 | 496.2 | 426.23 | 429.3 | 197.95 | Upgrade
|
| Total Debt | 1.85 | 5.23 | 8.44 | 2.05 | 2.05 | Upgrade
|
| Net Cash (Debt) | 305.73 | 458.6 | 386.95 | 407.2 | 189.93 | Upgrade
|
| Net Cash Growth | -33.33% | 18.51% | -4.97% | 114.39% | - | Upgrade
|
| Net Cash Per Share | 1.92 | 7.05 | 14.22 | 18.60 | 14.61 | Upgrade
|
| Filing Date Shares Outstanding | 161.98 | 158.89 | 32.61 | 31.98 | 30.61 | Upgrade
|
| Total Common Shares Outstanding | 161.71 | 158.83 | 32.61 | 31.98 | 30.61 | Upgrade
|
| Working Capital | 284.17 | 453.17 | 364.26 | 392.33 | 184.47 | Upgrade
|
| Book Value Per Share | 1.78 | 2.95 | -13.70 | -10.17 | -3.08 | Upgrade
|
| Tangible Book Value | 287.06 | 469.08 | -446.85 | -325.22 | -94.38 | Upgrade
|
| Tangible Book Value Per Share | 1.78 | 2.95 | -13.70 | -10.17 | -3.08 | Upgrade
|
| Machinery | 3.19 | 3.18 | 2.94 | 2.3 | 1.83 | Upgrade
|
| Construction In Progress | - | 0.04 | 0.51 | 0.22 | - | Upgrade
|
| Leasehold Improvements | - | - | 0.02 | 0.26 | 0.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.